HealingMaps Take: Dr. Benhuri brings elite academic credentials (UCLA, Mount Sinai) to a peptide focused practice in Beverly Hills. His dedicated peptide specialist positioning and active PR presence suggest a physician building a niche reputation rather than offering peptides as an afterthought. The combination of in office, telehealth, and house call options provides maximum flexibility.
Dr. Daniel Benhuri offers 6 specific peptide compounds (BPC-157, Tesamorelin, Semaglutide, Tirzepatide, PT-141, and NAD+), placing it in the top half of the 40+ California peptide clinics in our directory (the median clinic menu offers 4 compounds; the deepest offers 19). The clinic is physician-led (MD or DO); over half of California peptide clinics in our directory are. See our full editorial roundup of Los Angeles peptide clinics for how this listing fits into the metro picture.
✓ Last verified: April 16, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
| Review Scores | PR presence via Yahoo Finance and PR Newswire |
| Location | Beverly Hills, California |
| Address | 9400 Brighton Way, Suite 210, Beverly Hills, CA 90210 |
| Phone | (310) 362-1255 |
| Website | danielbenhurimd.com |
| Treatments | Semaglutide, Tirzepatide, BPC-157, Tesamorelin, PT-141, NAD+ |
| Conditions Treated | Weight loss, healing, hormone balance, sexual wellness, cellular rejuvenation |
| Administration | In office injection, Telehealth, Concierge house calls |
| Cost | N/A |
| Insurance | Cash pay (concierge model) |
| Clinical Lead | Dr. Daniel Benhuri, M.D. — Board certified internal medicine, UCLA undergraduate, Mount Sinai M.D. |
Your prescribing provider, Dr. Daniel Benhuri, is verified in the federal CMS National Plan & Provider Enumeration System (NPPES) under NPI 1003304189, with a primary specialty of Internal Medicine and a primary practice address in Beverly Hills, CA. CMS records show this NPI has been active since 2018. NPPES record verified 2026-05-08. Dr. Daniel Benhuri’s NPI tenure is among the more recently licensed of the 21 California peptide providers we’ve verified in NPPES (longest-tenured peer registered in 2005; cohort median 2007).
What this means for you: In the US, any actively state-licensed physician can legally prescribe compounded peptides — board certification in a specific specialty isn’t required for peptide prescriptions. Internal Medicine training focuses on chronic-disease and metabolic care that aligns with GLP-1 weight-loss and longevity peptide protocols.
Beverly Hills, CA pricing — based on 5 verified peptide clinics in our directory (April 2026 data). Adjust the calculator below to model your own protocol.
Most Dr. Daniel Benhuri patients report the consult-to-first-injection window runs 1–3 weeks depending on lab turnaround and pharmacy fulfillment.
The questions below are pulled from the gaps in this specific listing — areas the clinic doesn’t publicly answer that you should clarify before booking. Each one is designed to get you a useful answer in 30 seconds or less.
“Dr. Benhuri is thorough and clearly passionate about peptide therapy. He explained the science behind every recommendation and followed up personally. — Patient Review”
Dr. Daniel Benhuri operates an integrative and concierge medicine practice on Brighton Way in Beverly Hills. He completed his undergraduate education at UCLA and earned his medical degree at Mount Sinai. Dr. Benhuri has positioned himself as a dedicated peptide therapy specialist, offering semaglutide, tirzepatide, BPC-157, tesamorelin, PT-141, and NAD+. The practice offers in office consultations, telehealth, and concierge house calls throughout Los Angeles.
For more on how peptide therapy works, see our guide to peptide therapy.
Patients appreciate the academic credentials and the dedicated focus on peptide therapy. The triple delivery model (office, telehealth, house calls) fits the schedules of busy LA professionals.
Public patient reviews are limited compared to more established practices. The Beverly Hills concierge model likely carries premium pricing.
Schedule a consultation through the website, by phone, or request a concierge house call. Dr. Benhuri evaluates health goals and designs a peptide protocol. Telehealth follow ups are available.
Explore more vetted peptide therapy clinics near you in our nationwide directory.
Looking for more BPC-157 providers? Browse our directory of BPC-157 and recovery peptide clinics — including options in California across the United States.
Based on this listing, Dr. Daniel Benhuri names 6 specific peptide compounds: BPC-157, Tesamorelin, Semaglutide, Tirzepatide, PT-141, and NAD+. The clinic may offer additional compounds not published on its public listing — confirm the full menu on a consult call.
Yes. Dr. Daniel Benhuri is registered in the federal CMS National Plan & Provider Enumeration System (NPPES) under NPI 1003304189, with a primary specialty of Internal Medicine and a primary practice address in Beverly Hills, CA. The NPI has been active since 2018.
Yes — this listing mentions telehealth or virtual visits. In peptide therapy, the initial consult and lab review are most often in-person, but follow-up appointments can frequently be virtual once you’re stable on a protocol. Confirm specifics on the consult call, including which states the clinic can prescribe to via telehealth.
Among verified California peptide clinics in the HealingMaps directory, Dr. Daniel Benhuri ranks in the top half of California peptide clinics in the directory by compound depth. Compound depth is one signal among several — provider credentials, pharmacy sourcing transparency, and lab requirements also matter when comparing.
Dr. Daniel Benhuri is located in Beverly Hills, California. The full street address, phone number, and hours are listed in the data card above.
Themes drawn from HealingMaps editorial analysis of verified California peptide clinics in our directory + CDC PLACES 2023 (Los Angeles County, CA) + US Census ACS 5-Year. Refreshed quarterly; percentages rounded to nearest 5%.
Across California peptide clinics in our directory, BPC-157 appears in 55% of listings; Ipamorelin in 45%; CJC-1295 in 40%; Semaglutide in 35%. Compounds appearing in fewer than 20% of California listings — including Epitalon, Thymosin Alpha-1, Semax — are less commonly disclosed; patients seeking those should specifically ask whether the clinic prescribes them.
25% of California clinics in our directory openly state whether they use a 503A or 503B compounding pharmacy. The rest leave the class unstated. The distinction matters for patients — 503A pharmacies fill prescriptions individually after your provider writes them (typically a few-day wait, in-state shipping), while 503B outsourcing facilities pre-batch under direct FDA inspection (often supporting same-visit fulfillment and direct-to-home shipping). Worth asking specifically before you book.
55% of verified California clinics name an MD or DO as clinical lead (this listing’s clinical lead is Internal Medicine-trained). The remainder are NP/PA-led or don’t publicly name a specific prescribing clinician. Any state-licensed physician, NP, or PA can legitimately prescribe compounded peptides — but knowing your prescriber’s training and tenure helps you assess fit for your specific protocol.
The median California clinic in our directory publishes 4 specific peptide compounds on its listing. The deepest disclosed menu names 19; 25% of listings name no specific compounds at all. A wide menu means more options at one clinic; a narrow menu can reflect specialization (e.g. weight-loss-only programs) or limited public disclosure (the clinic prescribes more than it advertises).
In Los Angeles County, 26.5% of adults are obese (CDC PLACES 2023) — roughly at the national average — supporting balanced demand between weight-loss and longevity protocols. Diagnosed diabetes runs at 12.6%. 11.7% of adults lack health insurance, roughly average for the country.
45+ verified peptide clinics serve Los Angeles County’s ~9,721K residents (0.5 per 100K) — roughly average peptide-clinic density for U.S. metros. Comparing 3-5 clinics on consult calls is a reasonable benchmark before booking.
Pharmacy sourcing: This clinic doesn’t state its 503A or 503B compounding pharmacy partner. The class affects how your prescription is fulfilled — custom-compounded with in-state shipping (503A) versus pre-batched with broader shipping including direct-to-home delivery (503B) — so it’s worth asking before starting any compounded protocol.
Dr. Daniel Benhuri’s named prescriber is verifiable in the CMS National Plan & Provider Enumeration System — the highest single trust signal we look for. The clinic names 6 specific peptide compounds — including BPC-157, Tesamorelin, and Semaglutide. What’s not publicly stated: which pharmacy class (503A vs 503B) handles compounding. Worth asking on your consult call. See our full vetting rubric →
Leave a Reply